Update on the withdrawal of dopamine agonists in patients with hyperprolactinemia.

Purpose of reviewDespite the widespread use of dopamine agonists for patients with prolactinomas and symptomatic idiopathic hyperprolactinemia for many decades, the optimal treatment strategy and duration of treatment is still not evident. This review highlights the effects of dopamine agonist withd